A jama article meta analysis in 2018 covering studies concerning glp 1 agonists dpp 4 inhibitors and sglt2 inhibitors showed glp 1 agonists were associated with lower stroke risk than controls.
Glp 1 agonists side effects.
Side effects from long term use of glp 1s have been an area of concern.
Other common adverse effects include injection site reactions headache and nasopharyngitis but these effects do not usually result in discontinuation of the drug.
Glp 1 receptor agonists can cause nausea vomiting diarrhea headache weakness or dizziness.
3 ongoing pain in the upper left or middle of the stomach that may spread to the back with or without vomiting a skin rash or hives itching pounding heart dizziness or fainting swelling of the eyes face mouth tongue throat.
Incretin mimetics lower blood sugar in the human body by.
Nausea may improve with time and a lower dose.
Although rare these side effects should be treated as an emergency.
Since these drugs are relatively new there are limited studies to evaluate the claims of glp 1 induced pancreatitis.
The most common symptoms associated with the use of glp 1 receptor agonists are gastrointestinal symptoms mainly nausea.
Nausea vomiting and diarrhea can occur in many people.
Feelings of early fullness lower appetite nausea vomiting diarrhea.
Also it may occur less often with the.
While pancreatitis by itself is not a major concern chronic pancreatitis is linked to an increase in the risk for pancreatic cancer.
For example nausea and vomiting with abdominal pain could be pancreatitis inflammation of the pancreas.
Diarrhoea nausea vomiting headaches dizziness increased sweating indigestion constipation loss of appetite.
Possible side effects of incretin mimetics include.
Glp 1 ras commonly cause digestive side effects such as.
Some of the more common side effects include.
The most common side effects are gastrointestinal.
Side effects of incretin mimetics or glp 1 drugs may be the result of the way they work in the human body.